Aclarion, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
Aclarion, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 4, 2026, detailing proposals for director elections, ratification of its auditor, and an amendment to its equity incentive plan.
NASDAQ
Aclarion, Inc. has adjourned its Annual Meeting of Stockholders to July 21, 2025, to solicit additional votes for the proposals outlined in its definitive proxy statement.
NASDAQ
Aclarion, Inc. will hold its 2025 Annual Meeting of Stockholders on July 7, 2025, to vote on director elections, auditor ratification, a reverse stock split proposal, and an equity plan amendment.
NASDAQ
Aclarion, Inc. has adjourned its Special Meeting of Stockholders to March 5, 2025, to solicit additional votes regarding proposals outlined in the definitive proxy statement.
NASDAQ
Aclarion, Inc. is holding a special meeting of stockholders to approve the issuance of shares related to warrants and to increase the number of authorized shares of common stock.
NASDAQ
Aclarion, Inc. is holding its 2024 Annual Meeting of Stockholders on December 31, 2024, to vote on several key proposals, including the election of directors, ratification of auditors, and approval of stock issuances and a reverse stock split.
NASDAQ
Aclarion, Inc. is seeking stockholder approval for a reverse stock split, ranging from 1-for-5 to 1-for-50, to increase its stock price and regain compliance with Nasdaq listing requirements.